NCT03596034View on ClinicalTrials.gov

A Study to Characterize Puff Topography With Use of JUUL 5% Electronic Nicotine Delivery Systems (ENDS) in Adult Smokers

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 9, 2018

Primary Completion Date

September 26, 2018

Study Completion Date

September 26, 2018

Conditions
Tobacco UseNicotine Dependence, Other Tobacco ProductTobacco Smoking
Interventions
OTHER

JUUL 5%, Virginia Tobacco, ENDS product

Subjects participate in a 15 day product use period during which subjects will be requested to predominantly use the JUUL 5% product ad libitum as their primary source of nicotine. Subjects will be asked to report their daily use of the JUUL 5% product and CPD throughout the 15 day product use period.

Trial Locations (2)

27617

Rose Research Center Raleigh, Raleigh

28262

Rose Research Center Charlotte, Charlotte

All Listed Sponsors
collaborator

Rose Research Center, LLC

INDUSTRY

lead

Juul Labs, Inc.

INDUSTRY

NCT03596034 - A Study to Characterize Puff Topography With Use of JUUL 5% Electronic Nicotine Delivery Systems (ENDS) in Adult Smokers | Biotech Hunter | Biotech Hunter